Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue
J. Gogolok, E. Seidel, A. Strönisch, A. Reutzel-Selke, I.M. Sauer, J. Pratschke, M. Bahra, R.B. Schmuck

Laparoscopic Resection for Adenocarcinoma of the Stomach or Gastroesophageal Junction Improves Postoperative Outcomes: a Propensity Score Matching Analysis
A. Andreou, S. Knitter, S. Chopra, C. Denecke, M. Schmelzle, B. Struecker, A.C. Heilmann, J. Spenke, T. Hofmann, P.C. Thuss-Patience, M. Bahra, J. Pratschke, M. Biebl

The Falciform Ligament for Mesenteric and Portal Vein Reconstruction in Local Advanced Pancreatic Tumor: A Surgical Guide and Single-Center Experience
T. Malinka, F. Klein, T. Denecke, U. Pelzer, J. Pratschke, M. Bahra

Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer
C.C.M. Neumann, E. von Hörschelmann, A. Reutzel-Selke, E. Seidel, I.M. Sauer, J. Pratschke, M. Bahra, R.B. Schmuck

Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas
R.B. Schmuck, C. Brokat, A. Andreou, M. Felsenstein, F. Klein, B. Sinn, J. Pratschke, M. Bahra

Strengths, Weaknesses, Opportunities, and Threats of Centralized Pancreatic Surgery: a Single-Center Analysis of 3000 Consecutive Pancreatic Resections
F. Klein, U. Pelzer, R.B. Schmuck, T. Malinka, M. Felsenstein, T. Denecke, J. Pratschke, M. Bahra

Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival
F. Klein, F. Berresheim, M. Felsenstein, T. Malinka, U. Pelzer, T. Denecke, J. Pratschke, M. Bahra

Distal Pancreatectomy Combined with Multivisceral Resection Is Associated with Postoperative Complication Rates and Survival Comparable to Those After Standard Procedures
T. Malinka, F. Klein, A. Andreou, J. Pratschke, M. Bahra

Evaluation of Anastomotic Leak after Esophagectomy for Esophageal Cancer:
Typical Time Point of Occurrence, Mode of Diagnosis, Value of Routine Radiocontrast Agent Studies and Therapeutic Options
B. Struecker, A. Andreou, S. Chopra, A.C. Heilmann, J. Spenke, C. Denecke, I.M. Sauer, M. Bahra, J. Pratschke, M. Biebl

Bovine serum albumine-glutaraldehyde sealed fish-mouth closure of the pancreatic remnant during distal pancreatectomy
F. Klein, I.M. Sauer, J. Pratschke, M. Bahra

Bile: miRNA pattern and protein based biomarkers may predict acute cellular rejection after liver transplantation
R.B. Schmuck, A. Reutzel-Selke, N. Raschzok, M.H. Morgul, B. Struecker, S. Lippert, C. de Carvalho Fischer, M. Schmelzle, S. Boas-Knoop, M. Bahra, A. Pascher, J. Pratschke, I.M. Sauer

Routine radiologic contrast agent examination after gastrectomy for gastric cancer is not useful
B. Struecker, S. Chopra, A.C. Heilmann, J. Spenke, C. Denecke, I.M. Sauer, M. Bahra, J. Pratschke, A. Andreou, M. Biebl

The impact of tumor cell proliferation on occult micrometastases, tumor recurrence and patient outcome following resection for liver malignancies
A. Andreou, M. Schmelzle, I.M. Sauer, M. Bahra, J. Pratschke

Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer
A. Andreou, M. Biebl, M. Dadras, B. Struecker, I.M. Sauer, P.C. Thuss-Patience, S. Chopra, P. Fikatas, M. Bahra, D. Seehofer, J. Pratschke, S.C. Schmidt

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Noll EM, Eisen C, Stenzinger A, Espinet E, Muckenhuber A, Klein C, Vogel V, Klaus B, Nadler W, Rösli C, Lutz C, Kulke M, Engelhardt J, Zickgraf FM, Espinosa O, Schlesner M, Jiang X, Kopp-Schneider A, Neuhaus P, Bahra M, Sinn BV, Eils R, Giese NA, Hackert T, Strobel O, Werner J, Büchler MW, Weichert W, Trumpp A, Sprick MR. 

Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following orthotopic liver transplantation
Andreou A, Bahra M, Schmelzle M, Sucher R, Sauer IM, Guel-Klein S, Struecker B, Eurich D, Klein F, Pascher A, Pratschke J, Seehofer D.

Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival
Sinn M, Bahra M, Denecke T, Travis S, Pelzer U, Riess H. 

P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment
Striefler JK, Sinn M, Pelzer U, Jühling A, Wislocka L, Bahra M, Sinn BV, Denkert C, Dörken B, Oettle H, Riess H, Bläker H, Lohneis P.

Long-term Survival After Surgical Treatment of Renal Cell Carcinoma Metastasis Within the Pancreas
Fikatas P, Klein F, Andreou A, Schmuck RB, Pratschke J, Bahra M. 

Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a commor tumor entity
Schmuck RB, de Carvalho Fischer CV, Neumann C, Pratschke J, Bahra M

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial
Keck T, Wellner UF, Bahra M, Klein F, Sick O, Niedergethmann M, Wilhelm TJ, Farkas SA, Börner T, Bruns C, Kleespies A, Kleeff J, Mihaljevic AL, Uhl W, Chromik A, Fendrich V, Heeger K, Padberg W, Hecker A, Neumann UP, Junge K, Kalff JC, Glowka TR, Werner J, Knebel P, Piso P, Mayr M, Izbicki J, Vashist Y, Bronsert P, Bruckner T, Limprecht R, Diener MK, Rossion I, Wegener I, Hopt UT.

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial
Sinn M, Riess H, Sinn BV, Stieler JM, Pelzer U, Striefler JK, Oettle H, Bahra M, Denkert C, Bläker H, Lohneis P.

Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival
Kamphues C, Bova R, Bahra M, Klauschen F, Muckenhuber A, Sinn BV, Warth A, Goeppert B, Endris V, Neuhaus P, Weichert W, Stenzinger A.

The DNA index as a prognostic tool in hilar cholangiocarcinoma
Kamphues C, Al-Abadi N, Bova R, Rademacher S, Al-Abadi H, Klauschen F, Bahra M, Neuhaus P, Pratschke J, Seehofer D.

Cytoreductive Surgery for Pancreatic Cancer improves Overall Outcome of Gemcitabine-Based Chemotherapy
Bahra M, Pratschke J, Klein F, Neuhaus P, Boas-Knoop S, Puhl G, Denecke T, Pullankavumkal JR, Sinn M, Riess H, Pelzer U.

CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma: A Case Report and Review of the Literature
Rotzinger R, Bläker H, Bahra M, Denecke T, Grieser C.

CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation
N. Raschzok, A. Reutzel-Selke, R.B. Schmuck, M.H. Morgul, U. Gauger,K.A. Prabowo, L.-M. Tannus, A. Leder, B. Struecker, S. Boas-Knoop, M. Bartels, S. Jonas, Ch. Lojewski, G. Puhl, D. Seehofer, M. Bahra, A. Pascher, J. Pratschke, I.M. Sauer

Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer
Andreou A, Viganò L, Zimmitti G, Seehofer D, Dreyer M, Pascher A, Bahra M, Schoening W, Schmitz V, Thuss-Patience PC, Denecke T, Puhl G, Vauthey JN, Neuhaus P, Capussotti L, Pratschke J, Schmidt SC.

Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy
Sinn M, Ganeshan R, Graf R, Pelzer U, Stieler JM, Striefler JK, Bahra M, Wust P, Riess H.

DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study
Kamphues C, Al-Abadi N, Dürr A, Bova R, Klauschen F, Stenzinger A, Bahra M, Al-Abadi H, Neuhaus P, Seehofer D.

Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
D. Riedlinger, M. Bahra, S. Boas-Knoop, S. Lippert, M. Bradtmöller, K. Guse, D. Seehofer, R. Bova, I.M. Sauer, P. Neuhaus, A. Koch, C. Kamphues

Significant impact of patient age on outcome after liver resection for HCC in cirrhosis
Faber W, Stockmann M, Schirmer C, Möllerarnd A, Denecke T, Bahra M, Klein F, Schott E, Neuhaus P, Seehofer D.

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial
Pelzer U, Hilbig A, Stieler JM, Bahra M, Sinn M, Gebauer B, Dörken B, RiessPelzer U, Hilbig A, Stieler JM, Bahra M, Sinn M, Gebauer B, Dörken B, Riess

Radiologic resectability assessment in pancreatic cancer
Denecke T, Grieser C, Neuhaus P, Bahra M.

Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
Riedlinger D, Bahra M, Boas-Knoop S, Lippert S, Bradtmöller M, Guse K, Seehofer D, Bova R, Sauer IM, Neuhaus P, Koch A, Kamphues C.

KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma
Sinn BV, Striefler JK, Rudl MA, Lehmann A, Bahra M, Denkert C, Sinn M, Stieler J, Klauschen F, Budczies J, Weichert W, Stenzinger A, Kamphues C, Dietel M, Riess H. 

Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas
Riener MO, Thiesler T, Hellerbrand C, Amann T, Cathomas G, Fritzsche FR, Dahl E, Bahra M, Weichert W, Terracciano L, Kristiansen G. 

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
Sinn M, Denkert C, Striefler JK, Pelzer U, Stieler JM, Bahra M, Lohneis P, Dörken B, Oettle H, Riess H, Sinn BV.

Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer
Göhrig A, Detjen KM, Hilfenhaus G, Körner JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B, Fischer C.

Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy
Pelzer U, Hilbig A, Sinn M, Stieler J, Bahra M, Dörken B, Riess H.

Blood group determinates incidence for pancreatic cancer in Germany
Pelzer U, Klein F, Bahra M, Sinn M, Dörken B, Neuhaus P, Meyer O, Riess H.

Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study
Sinn M, Striefler JK, Sinn BV, Sallmon D, Bischoff S, Stieler JM, Pelzer U, Bahra M, Neuhaus P, Dörken B, Denkert C, Riess H, Oettle H.

The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma
Klein F, Puhl G, Guckelberger O, Pelzer U, Pullankavumkal JR, Guel S, Neuhaus P, Bahra M. 

Morphological analysis and differentiation of benign cystic neoplasms of the pancreas using computed tomography and magnetic resonance imaging
Grieser C, Heine G, Stelter L, Steffen IG, Rothe JH, Walter TC, Fischer C, Bahra M, Denecke T.

DNA Index as a Strong Prognostic Factor in Patients with Adenocarcinoma of the Pancreatic Head: Results of a 5-Year Prospective Study
Kamphues C, Al-Abadi H, Dürr A, Al-Abadi N, Schricke D, Bova R, Müller V, Stenzinger A, Klauschen F, Seehofer D, Neuhaus P, Bahra M.

Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Kamphues C, Wittschieber D, Klauschen F, Kasajima A, Dietel M, Schmidt SC, Glanemann M, Bahra M, Neuhaus P, Weichert W, Stenzinger A.

Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas
Bahra M, Kamphues C, Boas-Knoop S, Lippert S, Esendik U, Schüller U, Hartmann W, Waha A, Neuhaus P, Heppner F, Pietsch T, Koch A.

Postoperative complications deteriorate long-term outcome in pancreatic cancer patients
Kamphues C, Bova R, Schricke D, Hippler-Benscheidt M, Klauschen F, Stenzinger A, Seehofer D, Glanemann M, Neuhaus P, Bahra M.

Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy
Eurich D, Boas-Knoop S, Bahra M, Neuhaus R, Somasundaram R, Neuhaus P, Neumann U, Seehofer D.

High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer
Klauschen F, von Winterfeld M, Stenzinger A, Sinn BV, Budczies J, Kamphues C, Bahra M, Wittschieber D, Weichert W, Striefler J, Riess H, Dietel M, Denkert C.

Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma
Kamphues C, Seehofer D, Collettini F, Bahra M, Neuhaus P, Wust P, Denecke T, Gebauer B, Schnapauff D.

Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes
Winter C, Kristiansen G, Kersting S, Roy J, Aust D, Knösel T, Rümmele P, Jahnke B, Hentrich V, Rückert F, Niedergethmann M, Weichert W, Bahra M, Schlitt HJ, Settmacher U, Friess H, Büchler M, Saeger HD, Schroeder M, Pilarsky C, Grützmann R.

Matched-pair analysis of postoperative morbidity and mortality for pancreaticogastrostomy and pancreaticojejunostomy using mattress sutures in soft pancreatic tissue remnants
Klein F, Bahra M, Glanemann M, Faber W, Warnick P, Andreou A, Gül S, Jacob D.

Pancreatoenteral anastomosis or direct closure of the pancreatic remnant after a distal pancreatectomy: a single-centre experience
Klein F, Glanemann M, Faber W, Gül S, Neuhaus P, Bahra M.

Distal pancreatectomy with en bloc resection of the celiac trunk for extended pancreatic tumor disease: an interdisciplinary approach
Andreou A, Denecke T, Podrabsky P, Grieser C, Warnick P, Bahra M, Klein F, Hamm B, Neuhaus P, Glanemann M.

Distal pancreatectomy with en bloc resection of the celiac trunk for extended pancreatic tumor disease: an interdisciplinary approach
Denecke T, Andreou A, Podrabsky P, Grieser C, Warnick P, Bahra M, Klein F, Hamm B, Neuhaus P, Glanemann M.

Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience
Warnick P, Mai I, Klein F, Andreou A, Bahra M, Neuhaus P, Glanemann M.

Second-look operation in pancreatic carcinoma previously assessed as unresectable
Warnick P, Bahra M, Andreou A, Neuhaus P, Glanemann M.

Repeated liver resection for recurrent hepatocellular carcinoma
Faber W, Seehofer D, Neuhaus P, Stockmann M, Denecke T, Kalmuk S, Warnick P, Bahra M.

Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma
Eurich D, Boas-Knoop S, Morawietz L, Neuhaus R, Somasundaram R, Ruehl M, Neumann UP, Neuhaus P, Bahra M, Seehofer D.

Pancreas: Is there still a role for total pancreatectomy?
Bahra M, Neuhaus P.

Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival
Fotopoulou C, Savvatis K, Steinhagen-Thiessen E, Bahra M, Lichtenegger W, Sehouli J.

Second-look operation in pancreatic carcinoma previously assessed as unresectable
Warnick P, Bahra M, Andreou A, Neuhaus P, Glanemann M.

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G.

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G.

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas
Riener MO, Stenner F, Liewen H, Hellerbrand C, Bahra M, Kristiansen G.

Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases
Neumann UP, Thelen A, Röcken C, Seehofer D, Bahra M, Riess H, Jonas S, Schmeding M, Pratschke J, Bova R, Neuhaus P.

Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma
Riener MO, Pilarsky C, Gerhardt J, Grützmann R, Fritzsche FR, Bahra M, Weichert W, Kristiansen G.

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro in vivo
Lehmann A, Denkert C, Budczies J, Buckendahl AC, Darb-Esfahani S, Noske A, Müller BM, Bahra M, Neuhaus P, Dietel M, Kristiansen G, Weichert W.

Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up
Bahra M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P.

Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery?
Glanemann M, Shi B, Liang F, Sun XG, Bahra M, Jacob D, Neumann U, Neuhaus P.

Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas
Bahra M, Jacob D, Pascher A, Plockinger U, Kristiansen G, Neuhaus P, Langrehr JM.

Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes
Schumacher G, Hoffmann J, Cramer T, Spinelli A, Jacob D, Bahra M, Pratschke J, Pfitzmann R, Schmidt S, Lage H.

Jejunal loop drainage versus direct pancreatic duct drainage after pancreatic head resection
Jacob DA, Bahra M, Langrehr JM.

Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times
Kristiansen G, Jacob J, Buckendahl AC, Grützmann R, Alldinger I, Sipos B, Klöppel G, Bahra M, Langrehr JM, Neuhaus P, Dietel M, Pilarsky C.

Jejunal loop drainage versus direct pancreatic duct drainage after pancreatic head resection
Jacob DA, Bahra M, Langrehr JM.

Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer
Weichert W, Schmidt M, Jacob J, Gekeler V, Langrehr J, Neuhaus P, Bahra M, Denkert C, Dietel M, Kristiansen G.

Prospective randomized comparison between a new mattress technique and Cattell (duct-to-mucosa) pancreaticojejunostomy for pancreatic resection
Langrehr JM, Bahra M, Jacob D, Glanemann M, Neuhaus P.

Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter
Jacob D, Bahra M, Schumacher G, Neuhaus P, Fang B.

Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth
Schumacher G, Oidtmann M, Rosewicz S, Langrehr J, Jonas S, Mueller AR, Rueggeberg A, Neuhaus R, Bahra M, Jacob D, Gerlach H, Neuhaus P.